Clinical inertia in poorly controlled elderly hypertensive patients: A cross-sectional study in spanish physicians to ascertain reasons for not intensifying treatment

American Journal of Cardiovascular Drugs

Volumn 13, Issue 3, 2013, Pages 213-219

  Gil Guillén, Vicente ^a,b   Orozco Beltrán, Domingo ^a,c   Carratalá Munuera, Concepción ^a   Márquez Contreras, Emilio ^d   Durazo Arvizu, Ramón ^e   Cooper, Richard ^e   Pertusa Martínez, Salvador ^a   Pita Fernandez, Salvador ^f   González Segura, Diego ^a   Martin De Pablo, José Luis ^d   Pallarés, Vicente ^a   Fernández, Antonio ^a   Redón, Josep ^g  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b Hospital Elda   (Spain)

^c San Juan Hospital   (Spain)

^d Treatment Compliance and Inertia Research Group   (Spain)

^e LOYOLA UNIVERSITY CHICAGO   (United States)

^f UNIVERSITY OF A CORUÑA   (Spain)

^g UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BORDERLINE HYPERTENSION; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GERIATRIC CARE; GERIATRIC DISORDER; HUMAN; HYPERTENSION; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PHYSICIAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SPAIN; SYSTOLIC BLOOD PRESSURE;

AGED; ANTIHYPERTENSIVE AGENTS; CLINICAL COMPETENCE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PHYSICIAN-PATIENT RELATIONS; PHYSICIANS; SPAIN; TREATMENT OUTCOME;

EID: 84878562692     PISSN: 11753277     EISSN: 1179187X     Source Type: Journal    
DOI: 10.1007/s40256-013-0025-4     Document Type: Article

References (34)

1. Cushman WC, Ford CE, Cutler JA, Margolis KL, Davis BR, Grimm RH, et al. ALLHAT Collaborative Research Group. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich). 2002; 4(6):393-404.
2. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hyertension: final results of the systolic hypertension in the elderly program (SHEP). JAMA. 1991;265:3255-64.
3. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhäger WH, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997;350(9080):757-64.
4. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, et al. Clinical inertia. Ann Intern Med. 2001;135(9):825-34.
5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-52.
6. Phillips LS, Twombly JG. It's time to overcome clinical inertia. Ann Intern Med. 2008;148(10):783-5.
7. Okonofua EC, Simpson KN, Jesri A, Rehman SU, Durkalski VL, Egan BM. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension. 2006;47(3):345-51.
8. O'Connor PJ, Sperl-Hillen JAM, Johnson PE, Rush WA, Biltz G. Clinical inertia and outpatient medical errors. In: Henriksen K, Battles JB, Marks ES, Lewin DI, editors. Advances in patient safety: from research to implementation (vol. 2: concepts and methodology). Rockville (MD): Agency for Healthcare Research and Quality; 2005.
9. Redón J, Coca A, Lázaro P, Aguilar MD, Cabañas M, Gil N, Sánchez-Zamorano MA, Aranda P. Factors associated with therapeutic inertia in hypertension: validation of a predictive model. J Hypertens. 2010;28(8):1770-7.
10. Gil-Guillén V, Orozco-Beltrán D, Pérez RP, Alfonso JL, Redón J, Pertusa-Martínez S, et al. Clinical inertia in diagnosis and treatment of hypertension in primary care: quantification and associated factors. Blood Press. 2010;19(1):3-10.
11. Ferrari P, Hess L, Pechere-Bertschi A, Muggli F, Burnier M. Reasons for not intensifying antihypertensive treatment (RIAT): a primary care antihypertensive intervention study. J Hypertens. 2004;22(6):1221-9.
12. Oliveria SA, Lapuerta P, McCarthy BD, L'Italien GJ, Berlowitz DR, Asch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med. 2002;162(4):413-20.
13. Ferrari P; National Coordinators for the Reasons for not Intensifying Antihypertensive Treatment (RIAT) trial12. Reasons for therapeutic inertia when managing hypertension in clinical practice in non-Western countries. J Hum Hypertens. 2009; 23(3):151-9.
14. Márquez-Contreras E, Coca A, de la Figuera von Wichmann M, Divisón JA, Llisterri JL, Sobrino J, Control-Project Researchers, et al. Cardiovascular risk profile of uncontrolled hypertensive patients. The Control-Project study (in Spanish). Med Clin (Barc). 2007;128(3):86-91.
15. Gil-Guillén V, Orozco-Beltrán D, Márquez-Contreras E, Durazo-Arvizu R, Cooper R, Pita-Fernández S, et al. Is there a predictive profile for clinical inertia in hypertensive patients? An observational, cross-sectional, multicentre study. Drugs Aging. 2011;28(12):981-92.
16. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Management of Arterial Hypertension of the European Society of Hypertension, European Society of Cardiology, et al. 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (published erratum appears in J Hypertens. 2007 Aug; 25(8):1749). J Hypertens. 2007;25(6):1105-87.
17. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, European Society of Hypertension Working Group on Blood Pressure Monitoring, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens. 2003;21(5):821-48.
18. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens. 2009;27(11):2121-58.
19. Crescioni M, Gorina Y, Bilheimer L, Gillum RF. Trends in health status and health care use among older men. Natl Health Stat Report. 2010;24:1-18.
20. Wong ND, Lopez VA, L'Italien G, Chen R, Kline SE, Franklin SS. Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004. Arch Intern Med. 2007;167(22):2431-6.
21. Julius S, Weber MA, Kjeldsen SE, McInnes GT, Zanchetti A, Brunner HR, et al. The Valsartan antihypertensive long-term use evaluation (VALUE) trial: outcomes in patients receiving monotherapy. Hypertension. 2006;48(3):385-91.
22. Nasser SA, Lai Z, O'Connor S, Liu X, Flack JM. Does earlier attainment of blood pressure goal translate into fewer cardiovascular events? Curr Hypertens Rep. 2008; 10(5):398-404.
23. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, HYVET Study Group, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18):1887-98.
24. Milani RV. Reaching for aggressive blood pressure goals: role of angiotensin receptor blockade in combination therapy. Am J Manag Care. 2005;11(7 Suppl):S220-7.
25. Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, ACCOMPLISH trial investigators, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359(23):2417-28.
26. Ho PM, Magid DJ, Shetterly SM, Olson KL, Peterson PN, Masoudi FA, Rumsfeld JS. Importance of therapy intensification and medication non-adherence for blood pressure control in patients with coronary disease. Arch Intern Med. 2008;168(3):271-6.
27. Gorostidi M, Sobrino J, Segura J, Sierra C, de la Sierra A, Hernández del Rey R, Spanish Society of Hypertension ABPM Registry investigators, et al. Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20,000-patient database in Spain. J Hypertens. 2007;25(5):977-84.
28. Hyman DJ, Pavlik VN, Vallbona C. Physician role in lack of awareness and control of hypertension. J Clin Hypertens (Greenwich). 2000;2(5):324-30.
29. Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B, Moskowitz MA. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339(27):1957-63.
30. Federal Interagency Forum on Aging-Related Statistics. Older Americans 2010. Key indicators of well-being: federal interagency forum on aging-related statistics. Washington DC: US Government Printing Office; 2010.
31. el-Kebbi IM, Ziemer DC, Gallina DL, Dunbar V, Phillips LS. Diabetes in urban African-Americans. XV. Identification of barriers to provider adherence to management protocols. Diabetes Care. 1999; 22(10):1617-20.
32. Ogedegbe G. Barriers to optimal hypertension control. J Clin Hypertens (Greenwich). 2008;10(8):644-6.
33. Roumie CL, Elasy TA, Wallston KA, Pratt S, Greevy RA, Liu X, et al. Clinical inertia: a common barrier to changing provider prescribing behavior. Jt Comm J Qual Patient Saf. 2007;33(5):277-85.
34. Ortiz Tobarra MT, Orozco Beltrán D, Gil Guillén V, Terol Moltó C. Frequency of attendance and degree of control of type-2 diabetic patients (in Spanish). Aten Primaria. 2008; 40(3):139-44.